patient_id	feature_display	tested_subfeature	therapy_name	n_mut	n_wt	n_mut_tested	n_wt_tested	mut_ic50_median	mut_ic50_mean	mut_ic50_std	wt_ic50_median	wt_ic50_mean	wt_ic50_std	pvalue_mww	statistic
MEL-IPI_Pat103	BRAF p.D594N (Missense)	BRAF	Dabrafenib	264	1559	136	621	34.824	120.732	228.705	121.915	244.298	422.653	2.322e-12	58428.0
MEL-IPI_Pat103	BRAF p.D594N (Missense)	BRAF Somatic Variant	Dabrafenib	184	1639	98	659	19.092	80.76	176.13	120.697	243.118	416.712	7.627e-17	49130.0
MEL-IPI_Pat103	BRAF p.D594N (Missense)	BRAF Somatic Variant Missense	Dabrafenib	170	1653	89	668	19.04	82.289	184.013	119.74	240.726	414.446	6.330e-16	45390.0
MEL-IPI_Pat103	BRAF p.D594N (Missense)	BRAF Somatic Variant Missense p.D594N	Dabrafenib	0	1823	0	757				106.703	222.099	397.61	nan	
MEL-IPI_Pat103	BRAF p.D594N (Missense)	BRAF	Trametinib	264	1559	137	634	0.516	5.862	27.545	2.112	7.605	32.168	2.344e-09	57546.5
MEL-IPI_Pat103	BRAF p.D594N (Missense)	BRAF Somatic Variant	Trametinib	184	1639	99	672	0.364	4.887	30.17	2.152	7.65	31.568	9.083e-13	48043.5
MEL-IPI_Pat103	BRAF p.D594N (Missense)	BRAF Somatic Variant Missense	Trametinib	170	1653	90	681	0.271	5.095	31.639	2.147	7.586	31.365	2.900e-13	45139.0
MEL-IPI_Pat103	BRAF p.D594N (Missense)	BRAF Somatic Variant Missense p.D594N	Trametinib	0	1823	0	771				1.844	7.295	31.386	nan	
